• JP 3E Holdings’ majority-owned unit JP3E Development became Vivasor’s exclusive strategic representative in South Korea under a new agreement.
• Mandate covers business development for licensing, commercialization, manufacturing, investment, partnerships, corporate development, across Vivasor’s clinical-stage pipeline.
• JP3E will make Vivasor-approved introductions; Vivasor will negotiate and execute any definitive transactions directly with counterparties.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. JP 3E Holdings Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607221205PRIMZONEFULLFEED9766431) on July 22, 2026, and is solely responsible for the information contained therein.